Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof

InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof

US Patent 6033847 · Granted Mar 7, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antitumor agent and method for tumor therapy2024
Method for reducing content of saturated hydrocarbon, and refined palm-based oil2023
Antitumor drug for intermittent administration of FGFR inhibitor2021
Method and kits for identifying of CDK9 inhibitors for the treatment of cancer2019
Fluid treatment device and methods of use2019
Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a me2015
Dihydropyrazolopyrimidinone derivatives2014
Combination cancer therapy with an AKT inhibitor and other anticancer agents2013
Substrate, semiconductor device using the same, method for inspecting semiconduc2011
Dihydropyrazolopyrimidinone derivatives2011
Substituted pyrazolo[3,4-d]pyrimidinone derivatives2010
Selective inhibitors against Cdk4 and Cdk6 having aminothiazole skeleton2010